Can chronic spontaneous urticarial produce symptoms of neuropathic pain?


Gürel G., SAÇMACI H.

Anais Brasileiros de Dermatologia, cilt.98, sa.3, ss.296-301, 2023 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 98 Sayı: 3
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1016/j.abd.2022.06.004
  • Dergi Adı: Anais Brasileiros de Dermatologia
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.296-301
  • Anahtar Kelimeler: Chronic spontaneous urticarial, Neuropathic pain, Pruritus
  • Yozgat Bozok Üniversitesi Adresli: Evet

Özet

Background: Chronic spontaneous urticaria (CSU) is a condition that is associated with recurrent pruritic hives and/or angioedema lasting for more than 6 weeks and is known to affect 1% of the population. Neuropathic pain can be defined as abnormal pain in the peripheral or central nervous system following injury and results from dysfunctions in the peripheral or central nervous system without peripheral nociceptor stimulation. Histamine appears in the pathogenesis of both the CSU and diseases of the neuropathic pain spectrum. Objective: To evaluate the symptoms of neuropathic pain in patients with CSU using scales. Method: Fifty-one patients with CSU and 47 sex- and age-matched healthy controls were included in the study. Results: The results of the short-form McGill Pain Questionnaire revealed the scores in the sensory and affective domains, Visual Analogue Scale (VAS) scores and pain indices to be significantly higher in the patient group (p < 0.05 for all cases), while the overall pain assessment and sensory assessment based on the Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale were also significantly higher in the patient group. Based on the assumption that scores of > 12 indicated neuropathy, 27 (53%) of the patients in the patient group and 8 (17%) in the control group were found to have neuropathy (p < 0.05). Study limitations: Cross-sectional study, small patient sample and use of self-reported scales. Conclusion: In addition to itching, patients with CSU should be aware of the potential for the association of neuropathic pain. In this chronic disease that is known to affect the quality of life, using an integrated approach with the patients and identifying accompanying problems are as important as treating the dermatological disorder.